A Singapore-based organisation is working with industry members and national authorities to build regulatory capacity and encourage policy innovation in Asia, making the road to reaching Asian customers a less bumpy one for healthcare companies.
Enhancing the regulatory environment for companies
While Asia’s massive population offers an exciting opportunity for growth-seeking healthcare businesses, the speed at which they can roll out their products in the region hinges on an important factor: the complex and critical task of navigating the regulatory environment and systems for pharmaceutical products and medical devices across the region. Peoples’ health and well-being depend on sound regulatory frameworks that help them to access the safe and quality treatments they need in a timely way.
This is a challenge the Centre of Regulatory Excellence (CoRE) at Duke-NUS Medical School in Singapore recognises.